LUND, Sweden, Feb. 18, 2026 /PRNewswire/ — Hansa Biopharma AB, (“Hansa” or “the Company”), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase has ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase ...

CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today announced that it has entered into a strategic transaction ...

South End leaders proposed a tougher, tightly coordinated plan to confront open drug use and homelessness at Boston's ...

Diabetes and kidney disease are major risk factors for heart disease, yet many cases are undiagnosed. In addition, a consumer survey done last fall suggests that most people don't realize that their ...

By Dr. Priyom Bose, Ph.D. Tracking nearly 30,000 older Americans over eight years, researchers show that long-term exposure ...

Sports-related ocular injuries represent a significant percentage of ocular trauma cases.With the growing number of people participating in sports and recreational physical activities, the incidence ...

In this study, the researchers analyzed more than 275 million T-cell receptor sequences from over 2,200 individuals and used artificial intelligence ...

MyFitnessCoach has launched comprehensive Prehab, Rehab, and Mobility workout programs designed to help users prevent ...

Background Approximately one in three patients with acute ischemic stroke (AIS) suffer from a premorbid disability prior to ...

PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative ...

Background Adults with Tourette syndrome (ATS) face increased risks of self-injury behaviours (SIBs) and suicidality, yet research has largely focused on biological factors. Despite stigma being a ...